BILLS-117hr2067ih.pdf
House Resolutions
0 pages
Page
of 0
Loading OCR text...
No OCR text available for this page.
Failed to load OCR text.
DATE (9)
04:47 May 19, 2021
2067
5-year
8
years 2022 through 2027
11
year
1ST SESSION H. R. 2067
180 or more days
MARCH 18, 2021
2021
EVENT (3)
the ‘‘MATE Act
the ‘‘Medication Access
the ‘ACCME’
FAC (8)
PO 00000
Frm 00001
PO 00000
Frm 00005
PO 00000
Frm 00006
PO 00000
Frm 00002
PO 00000
Frm 00008
Fmt
PO 00000
Frm 00007
PO 00000
Frm 00004
PO 00000
Frm 00003
Fmt
GPE (4)
the United States
IH
Georgia
the United States of America
NORP (2)
American
APPROPRIATIONS.—To
ORG (32)
DSK79L0C42PROD
State
American Osteopathic Association
SEC
House of Representa-
Access and Training Expansion Act
Medical Education
the American Society of Ad-
3
diction Medicine
the American Board
the American Osteopathic Association
Psychiatric
Association
American Society of Addiction Medicine
THE HOUSE OF REPRESENTATIVES
the Committee on the Judiciary
Senate
the American Academy of Physi-
American Association of
Congress
the Accreditation Council
Food
the Public Health Service Act
Medical Specialties
the American Medical Association
American Psychiatric Association
the Food and Drug Administra-
OPIOID
American Medical Association
the Committee on Energy and Commerce
the American Academy of Addiction Psy-
Drug Administration
U.S.C.
PERSON (6)
ACCME
CARTER
TRAHAN
TONKO
MCKINLEY
TRONE
Topic Classifications
congressional legislation
94.9%
government oversight
38.6%
public health
23.3%
Extracted Keywords
practitioner
use disorders
opioid
addiction
controlled substances
physician
substance use
substances
disorders
medicine
managing
substance
treating
accredited
patients
Forensic Analysis
PDF Metadata
- Creator
- U.S. Gov. Printing Office -- G.S.D.D.
- ModDate
- D:20221230185547Z
- Producer
- Acrobat Distiller 21.0 (Windows); modified using iText® Core 7.2.3 (production version) ©2000-2022 iText Group NV, Government Publishing Office
- CreationDate
- D:20210520214321-04'00'
Sentiment
Polarity
Neutral
0.033
Subjectivity
24%
Objective